Top compounds associated with response to TIGD7


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.067 0.05
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.071 0.05
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.1 0.05
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA ML162 CTRPv2 pan-cancer AAC 0.07 0.05
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.076 0.05
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.11 0.06
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 0.06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.06
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.069 0.06
Download CSV